XML 88 R77.htm IDEA: XBRL DOCUMENT v3.21.2
Capital Stock and Reserves - Additional Information (Details)
$ / shares in Units, ¥ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
CNY (¥)
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2020
$ / shares
Dec. 31, 2020
USD ($)
shares
Sep. 30, 2021
CNY (¥)
shares
Apr. 30, 2021
USD ($)
Jun. 11, 2020
shares
Jul. 01, 2017
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Share-based compensation costs recorded for the period $ 6,100,000     $ 5,300,000 $ 18,200,000   $ 16,000,000.0            
Stock-based compensation expense $ 6,109,000     $ 5,310,000 $ 18,211,000   $ 15,969,000            
Maximum number of shares of common stock may be issued for outstanding PSU | shares 59,082,275   59,082,275   59,082,275 59,082,275     58,921,731 59,082,275      
Common shares purchased in open market by trustee in connection with RSUs | shares 0 0     0   200,000            
Weighted average price of common shares purchased in open market by trustee in connection with RSUs | $ / shares             $ 15.43            
Number of treasury shares held in trust for future settlement of share based awards | shares         276       723        
Value of treasury shares held in trust for future settlement of RSUs and stock options $ 4,000   $ 4,000   $ 4,000 $ 4,000     $ 11,000        
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares 6,115,389 6,115,389   6,959,515 6,115,389   6,959,515            
Percentage of statutory net profits to statutory surplus reserve to be appropriated. 10.00%   10.00%   10.00% 10.00%       10.00%      
Discontinuation of contribution, Aggregate sum of statutory surplus reserve more than its registered capital,percent. 50.00%   50.00%   50.00% 50.00%       50.00%      
Statutory surplus reserve appropriated $ 5,600,000   $ 5,600,000   $ 5,600,000 $ 5,600,000       ¥ 36.4      
Dividends declared and paid $ 20,400,000 ¥ 131.6                      
Statutory surplus reserve to its subsidiaries registered capital percent 50.00%   50.00%   50.00% 50.00%       50.00%      
IMAX China                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Details of the share repurchase program         In 2021, IMAX China announced that its shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of May 6, 2021 (34,835,824 shares). This program will be valid until the 2022 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.                
Stock Repurchase Program Expiration Date         May 06, 2021                
Repurchase of common shares | shares 3,569,000 3,569,000     3,569,000   906,400            
Stock Acquired, Average Cost per Share | (per share) $ 1.40   $ 10.90   $ 1.40 $ 10.90 $ 1.69 $ 13.13          
Stock Repurchase Program, maximum percentage of shares to be repurchased                       10.00%  
Stock Repurchase Program, Authorized number of shares | shares                       34,835,824  
Parent [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Details of the share repurchase program         In April 2021, the Company’s Board of Directors approved a 12-month extension to its share repurchase program through June 30, 2022. The extension authorized the Company to repurchase up to approximately $89.4 million worth of common shares, the remaining amount available of the original $200.0 million initially authorized under the share repurchase program when it commenced on July 1, 2017. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.                
Stock Repurchase Program, Authorized Amount                         $ 200,000,000.0
Stock Repurchase Program Expiration Date         Jun. 30, 2022                
Repurchase of common shares | shares 316,812 316,812     316,812   2,484,123            
Stock Acquired, Average Cost per Share | $ / shares $ 14.53       $ 14.53   $ 14.72            
Statutory surplus reserve appropriated $ 3,900   $ 3,900   $ 3,900 $ 3,900              
Non-controlling Interests [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Statutory surplus reserve appropriated 1,700   1,700   1,700 1,700              
Maximum [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Value of treasury shares held in trust for future settlement of RSUs and stock options 100,000   $ 100,000   100,000 $ 100,000     $ 100,000        
Maximum [Member] | Parent [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock Repurchase Program, Authorized Amount                     $ 89,400,000    
Restricted Share Units [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock-based compensation expense $ 3,900,000     $ 3,430,000 $ 11,524,000   $ 10,866,000            
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares 1,592,965 1,592,965   1,674,348 1,592,965   1,674,348            
Restricted Share Units [Member] | Minimum [Member] | Certain Advisor [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock-based compensation expense       $ 100,000            
Employee Stock Option [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock-based compensation expense $ 253,000     $ 433,000 $ 808,000   $ 1,449,000            
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares 3,738,504 3,738,504   4,917,428 3,738,504   4,917,428            
Performance Stock Units [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock-based compensation expense $ 1,183,000     $ 483,000 $ 3,169,000   $ 1,229,000            
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares 783,920 783,920   367,739 783,920   367,739            
Performance Stock Units [Member] | Maximum [Member] | EBITDA                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Maximum number of shares of common stock may be issued for outstanding PSU | shares 1,079,372   1,079,372   1,079,372 1,079,372       1,079,372